These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3935849)

  • 1. [Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].
    Furkalo NK; Ivashchenko TI; Romanenko AI
    Kardiologiia; 1985 Sep; 25(9):55-9. PubMed ID: 3935849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
    Lehmann HU; Brix W; Hochrein H
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1149-51. PubMed ID: 40120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various aspects of drug therapy of chronic forms of ischemic heart disease].
    Kipshidze NN; Chumburidze VB
    Kardiologiia; 1985 Sep; 25(9):37-40. PubMed ID: 2867241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
    Lehmann HU; Ziegler G; Hochrein H
    Med Welt; 1980 Jul; 31(29-30):1099-103. PubMed ID: 6774198
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
    Martorana PA; Kettenbach B; Göbel H; Nitz RE
    Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].
    Korabel'shchikova NI; Bichko MV; Rishko NV
    Vrach Delo; 1985 Apr; (4):19-21. PubMed ID: 3892905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 9. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of using corvaton on patients with unstable stenocardia].
    Vakaliuk IP
    Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass].
    Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E
    Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of anti-anginal therapy on the functional state of the myocardium in patients with chronic ischemic heart disease].
    Adamian KG; Asatrian MA; Oganesian LS; Grigorian NKh; Akopian BR
    Kardiologiia; 1985 Sep; 25(9):52-5. PubMed ID: 3935848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.